← Back to Search

HHD Measurement for Muscle Strength in Stroke Patients

N/A
Recruiting
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability to follow two-step commands
Age 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will test if HHD can more accurately measure leg muscle strength in stroke patients to better inform therapy.

Who is the study for?
This trial is for adults over 18 who've had a stroke at least 3 months ago and can follow simple commands. They must be able to hold certain positions like sitting or lying down during tests. People with severe limb stiffness, unstable vital signs, symptoms like shortness of breath or dizziness, active infections at the test site, or other serious health issues affecting physical activity cannot join.Check my eligibility
What is being tested?
The study is testing if hand-held dynamometry (HHD), a tool for measuring muscle strength in the legs, can provide accurate data for therapists treating patients with chronic stroke. It will measure normal values of leg muscle force in different ways to see how well it works.See study design
What are the potential side effects?
There are no direct side effects mentioned from using HHD as it's a non-invasive measurement tool. However, participants may experience general fatigue or discomfort from maintaining test positions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can understand and follow two-step instructions.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hand-held Dynamometry Measurement of Average Force Production
Secondary outcome measures
Hand-held Dynamometry Measurement of Peak Force Production
Other outcome measures
Hand-held Dynamometry Measurement of Time to Peak Force

Trial Design

1Treatment groups
Experimental Treatment
Group I: Average Force ProductionExperimental Treatment1 Intervention
Average force production of bilateral lower extremities will be collected using the handheld dynamometer, Activbody Activ5.

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
857 Previous Clinical Trials
672,173 Total Patients Enrolled
11 Trials studying Stroke
6,378 Patients Enrolled for Stroke

Media Library

Average Force Production Clinical Trial Eligibility Overview. Trial Name: NCT05941962 — N/A
Stroke Research Study Groups: Average Force Production
Stroke Clinical Trial 2023: Average Force Production Highlights & Side Effects. Trial Name: NCT05941962 — N/A
Average Force Production 2023 Treatment Timeline for Medical Study. Trial Name: NCT05941962 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots in this clinical research?

"Data hosted on clinicaltrials.gov reveals that the trial is currently searching for participants - this study was initially made visible to the public on June 5th 2023 and has been recently updated as of July 11th, 2023."

Answered by AI

What is the participant count for this research endeavor?

"Affirmative. The information on clinicaltrials.gov shows that this trial is actively seeking participants, with the original post date of June 5th 2023 and the most recent update occurring July 11th 2023. There are plans to recruit a total of 20 individuals from a single location."

Answered by AI
~11 spots leftby Jul 2025